Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.002 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.003 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |